Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126186962 | 12618696 | 2 | F | 20160915 | 20160803 | 20160923 | EXP | US-AMGEN-USASP2016098175 | AMGEN | 44.00 | YR | A | F | Y | 69.40000 | KG | 20160923 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126186962 | 12618696 | 1 | PS | ARANESP | DARBEPOETIN ALFA | 1 | Subcutaneous | UNK | U | 103951 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||||
| 126186962 | 12618696 | 2 | C | PROCRIT | ERYTHROPOIETIN | 1 | Unknown | 20.000 UNIT, QWK | U | 0 | SOLUTION FOR INJECTION | /wk | |||||||
| 126186962 | 12618696 | 3 | C | PULMICORT TURBUHALER | BUDESONIDE | 1 | 0.5 MG/2 ML, UNK | 0 | .5 | MG | |||||||||
| 126186962 | 12618696 | 4 | C | KLONOPIN | CLONAZEPAM | 1 | 0.5 MG, UNK | 0 | .5 | MG | |||||||||
| 126186962 | 12618696 | 5 | C | CATAPRES | CLONIDINE HYDROCHLORIDE | 1 | 0.3 MG, UNK | 0 | .3 | MG | |||||||||
| 126186962 | 12618696 | 6 | C | CARDURA | DOXAZOSIN MESYLATE | 1 | 8 MG, UNK | 0 | 8 | MG | |||||||||
| 126186962 | 12618696 | 7 | C | FERROUS SULFATE. | FERROUS SULFATE | 1 | 325 MG, UNK | 0 | 325 | MG | |||||||||
| 126186962 | 12618696 | 8 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 50 MUG, UNK | 0 | 50 | UG | |||||||||
| 126186962 | 12618696 | 9 | C | NEPHRO VITE RX | ASCORBIC ACIDBIOTINCALCIUM PANTOTHENATECYANOCOBALAMINFOLIC ACIDNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVINTHIAMINE MONONITRATE | 1 | 0.8 MG, UNK | 0 | .8 | MG | |||||||||
| 126186962 | 12618696 | 10 | C | APRESOLINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 126186962 | 12618696 | 11 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 126186962 | 12618696 | 12 | C | DULERA | FORMOTEROL FUMARATE DIHYDRATEMOMETASONE FUROATE | 1 | 100-5 MCG | 0 | |||||||||||
| 126186962 | 12618696 | 13 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 126186962 | 12618696 | 14 | C | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 126186962 | 12618696 | 15 | C | DELTASONE | PREDNISONE | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 126186962 | 12618696 | 16 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | 648 MG, UNK | 0 | 648 | MG | |||||||||
| 126186962 | 12618696 | 17 | C | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | 15 G/60 ML, UNK | 0 | 15 | G | |||||||||
| 126186962 | 12618696 | 18 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | 0.5 MG, UNK | 0 | .5 | MG | |||||||||
| 126186962 | 12618696 | 19 | C | ROCALTROL | CALCITRIOL | 1 | 0.25 MUG, UNK | 0 | .25 | UG | |||||||||
| 126186962 | 12618696 | 20 | C | LASIX | FUROSEMIDE | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 126186962 | 12618696 | 21 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | 325 MG, UNK | 0 | 325 | MG | |||||||||
| 126186962 | 12618696 | 22 | C | FLORANEX | LACTOBACILLUS ACIDOPHILUSLACTOBACILLUS DELBRUECKII SUBSP. BULGARICUS | 1 | 1 MILLION CELL | 0 | |||||||||||
| 126186962 | 12618696 | 23 | C | PRINIVIL | LISINOPRIL | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 126186962 | 12618696 | 24 | C | ZESTRIL | LISINOPRIL | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 126186962 | 12618696 | 25 | C | CARDENE | NICARDIPINE HYDROCHLORIDE | 1 | 30 MG, UNK | 0 | 30 | MG | |||||||||
| 126186962 | 12618696 | 26 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | 40 MG, UNK | 0 | 40 | MG | |||||||||
| 126186962 | 12618696 | 27 | C | CARAFATE | SUCRALFATE | 1 | 1 G, UNK | 0 | 1 | G | |||||||||
| 126186962 | 12618696 | 28 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 10 MG, UNK | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126186962 | 12618696 | 1 | Anaemia |
| 126186962 | 12618696 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126186962 | 12618696 | HO |
| 126186962 | 12618696 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126186962 | 12618696 | Abdominal pain | |
| 126186962 | 12618696 | Anxiety | |
| 126186962 | 12618696 | Clostridium difficile colitis | |
| 126186962 | 12618696 | Constipation | |
| 126186962 | 12618696 | Cough | |
| 126186962 | 12618696 | Drug effect decreased | |
| 126186962 | 12618696 | Dyspnoea | |
| 126186962 | 12618696 | Feeling abnormal | |
| 126186962 | 12618696 | Haemoglobin abnormal | |
| 126186962 | 12618696 | Headache | |
| 126186962 | 12618696 | Hyperkalaemia | |
| 126186962 | 12618696 | Hypertension | |
| 126186962 | 12618696 | Hypertensive crisis | |
| 126186962 | 12618696 | Hypotension | |
| 126186962 | 12618696 | Metabolic acidosis | |
| 126186962 | 12618696 | Pancreatitis | |
| 126186962 | 12618696 | Pneumonia | |
| 126186962 | 12618696 | Pneumonia pseudomonal | |
| 126186962 | 12618696 | Pyrexia | |
| 126186962 | 12618696 | Tachycardia | |
| 126186962 | 12618696 | Tracheobronchitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126186962 | 12618696 | 2 | 201602 | 0 |